Insider trading

Period: 12 months Stock: NVCR Type of trade: Sold × Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

24 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

24 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

24 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

24 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
24 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
24 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

24 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Jun 2026
Leonard Frank X Chief Executive Officer
Sold at will
$614.63K 34,273 at 17.93
6.9%
Not planned
2 Jun 2026
Hung David Director
Sold at will
$46.44K 2,945 at 15.77
12.6%
Not planned
2 Jun 2026
VERNON W ANTHONY Director
Sold at will
$46.44K 2,945 at 15.77
1.5%
Not planned
2 Jun 2026
HILLEMAN JERYL L Director
Sold at will
$46.44K 2,945 at 15.77
17.5%
Not planned
2 Jun 2026
Sold at will
$46.44K 2,945 at 15.77
17.1%
Not planned
2 Jun 2026
Ocean Allyson J Director
Sold at will
$46.44K 2,945 at 15.77
20.6%
Not planned
2 Jun 2026
Stafford Kristin Director
Sold at will
$46.44K 2,945 at 15.77
20.6%
Not planned
2 Jun 2026
LEUNG GABRIEL Director
Sold at will
$46.44K 2,945 at 15.77
3.2%
Not planned
5 Mar 2026
Paravasthu Mukund Chief Operating Officer
Sold at will
$595.67K 43,246 at 13.77
37.3%
Not planned
4 Mar 2026
Weinberg Uri Chf Medical and Innovation Ofr
Sold at will
$85.31K 6,412 at 13.31
2.3%
Not planned
4 Mar 2026
Brackmann Christoph Chief Financial Officer
Sold at will
$85.31K 6,412 at 13.31
3.4%
Not planned
4 Mar 2026
Leonard Frank X Chief Executive Officer
Sold at will
$74.60K 5,607 at 13.31
1.1%
Not planned
4 Mar 2026
Paravasthu Mukund Chief Operating Officer
Sold at will
$71.54K 5,377 at 13.31
4.4%
Not planned
4 Mar 2026
Puri Michal Nath Chief Human Resources Officer
Sold at will
$14.64K 1,100 at 13.31
0.5%
Not planned
4 Mar 2026
Leupin Nicolas Former Chief Medical Officer
Sold at will
$14.64K 1,100 at 13.31
1.1%
Not planned
3 Mar 2026
DOYLE WILLIAM F Executive Chairman
Sold at will 2×
$932.88K 71,887 at 12.98
18.0%
Not planned
2 Mar 2026
Leonard Frank X Chief Executive Officer
Sold at will
$97.58K 7,232 at 13.49
2.0%
Not planned
2 Mar 2026
Weinberg Uri Chf Medical and Innovation Ofr
Sold at will
$43.61K 3,272 at 13.33
1.4%
Not planned
2 Mar 2026
Paravasthu Mukund Chief Operating Officer
Sold at will
$5.51K 408 at 13.49
0.5%
Not planned
27 Feb 2026
Leonard Frank X Chief Executive Officer
Sold at will
$133.00K 9,734 at 13.66
2.8%
Not planned
27 Feb 2026
Weinberg Uri Chf Medical and Innovation Ofr
Sold at will
$103.26K 7,461 at 13.84
3.4%
Not planned
27 Feb 2026
Paravasthu Mukund Chief Operating Officer
Sold at will
$21.25K 1,555 at 13.66
2.0%
Not planned
27 Feb 2026
Puri Michal Nath Chief Human Resources Officer
Sold at will
$19.69K 1,441 at 13.66
0.9%
Not planned
27 Feb 2026
Leupin Nicolas Former Chief Medical Officer
Sold at will
$14.06K 1,029 at 13.66
1.0%
Not planned
Showing 1–24 of 24.